Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06738355Not ApplicableCompleted

PREVENT Pilot HPV - Related Cancers Trial

Role: collaborator

NCT07217145Not ApplicableActive Not Recruiting

PREVENT HPV -Related Cancers Trial

Role: collaborator

NCT05394844Not ApplicableCompleted

Diabetes Education With Real-time Continuous Glucose Monitoring

Role: collaborator

NCT06290206Not ApplicableCompleted

PREVENT HPV-Related Cancers - BootCamp Translation

Role: collaborator

NCT03925883Not ApplicableCompleted

Predicting and Addressing Colonoscopy in Safety Net Settings

Role: collaborator

All 5 trials loaded